Insulin solution, human recombinant

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, awarded a purchase order (PO 4800175896) to Sigma Aldrich Inc. on February 3, 2026, for the procurement of human recombinant insulin solution. The contract, valued at $268, encompasses a single unit of Insulin Solution, Human Recombinant (material number I9278-5ML), to be delivered to UNMC Shipping and Receiving at 601 South Saddle Creek Road, Omaha, Nebraska 68106, by the completion date of February 26, 2026. The contracting organization is located in Nebraska.

The purchase order is governed by the University of Nebraska's Standard Terms of Purchase and specifies F.O.B. destination shipping with freight prepaid and Net 30 payment terms. Sigma Aldrich Inc., the prime contractor and vendor of record, is located in Chicago, Illinois. The vendor is required to acknowledge acceptance of the purchase order within 10 days of the order date and to include the purchase order number on all packages, invoices, and related documentation. The University's tax-exempt status number is 05-8905401.